News

addition of hydrochlorothiazide 12.5 mg/d; up-titration of hydrochlorothiazide to 25 mg/d; addition of amlodipine besylate 5 mg/d; and up-titration of amlodipine besylate to 10 mg/d. Patients who ...
Medpage Today on MSN17h
FDA Approves Mepolizumab for COPD
Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...
JSW MG Motor India launched the Windsor EV in the Indian market in 2024. Since then, the electric vehicle has earned an elite status in the automaker's lineup by bringing in good sales numbers.
MG has taken its all-electric Windsor EV and given ... you can buy the car for just Rs 13.10 lakh plus Rs 4.5 per km for the battery usage. Here's a breakdown of the top 5 improvements that ...
Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
Mepolizumab added to triple therapy improves exacerbation outcomes in moderate to severe COPD and is effective to 2 years of ...
The right online broker can help you execute your investment strategy and make trading cheap stocks seamless. Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap ...
FDA approves mepolizumab (Nucala; GSK) as the first monthly biologic for chronic obstructive pulmonary disease (COPD), significantly reducing exacerbations in patients with an eosinophilic phenotype.
The 2025 MG S5 EV – the SUV version of the popular MG 4 electric hatch – will undercut the cheapest version of the BYD Atto 3 by $500 to $2500, and become the country's most affordable small ...
Dupilumab and omalizumab are both effective adjuvant treatments for adults with bullous pemphigoid, though dupilumab may ...
Yonsei University College of Medicine-led research has shown amiloride is as effective as spironolactone in reducing systolic ...